What is Medlab?
Medlab, Inc. operates as a sophisticated clinical laboratory focused on specialized testing services, including toxicology, molecular diagnostics, and pain management. The company offers a comprehensive PCR test for prevalent respiratory illnesses such as COVID-19, Flu, and RSV, delivering results rapidly, often within the same or next day. Medlab's commitment to enhancing community health and supporting healthcare providers is evident in its advanced testing technologies, which aid in the diagnosis and treatment of conditions ranging from substance abuse to chronic pain. Their services are tailored for healthcare professionals, judicial systems, and public health organizations, ensuring the delivery of accurate and timely diagnostic information.
How much funding has Medlab raised?
Medlab has raised a total of $16.3M across 2 funding rounds:
Series D
$16M
Debt
$250K
Series D (2008): $16M with participation from Chrysalis Ventures, Primus Capital, and Oxford Bioscience Partners
Debt (2025): $250K led by M&T Bank
Key Investors in Medlab
Chrysalis Ventures
Chrysalis Ventures is an investment firm that partners with technology-enabled businesses across various sectors, including healthcare, with a focus on underserved markets. They aim to foster growth through organic development and acquisitions.
Primus Capital
Primus Capital is a growth-oriented private equity firm investing in healthcare, software, and technology-enabled services, providing equity capital for middle-market businesses to accelerate growth.
Oxford Bioscience Partners
Oxford Bioscience Partners is an international venture capital firm with a specialization in life science technology investments, operating across the US and Korea.
What's next for Medlab?
With a major strategic investment and substantial total funding, Medlab is poised for significant expansion and enhancement of its diagnostic capabilities. The enterprise-level capital likely supports scaling operations, advancing technological infrastructure, and potentially broadening its service offerings in molecular diagnostics and specialized testing. This strategic financing is expected to solidify Medlab's position in supporting healthcare providers and public health initiatives through reliable and rapid diagnostic solutions.
See full Medlab company page
